HCBD-Pro Services
Client Subscribers
HIPN Daily Archive
No Password Required
HIPN Daily SignUp
free e-newsletter
No Password Required
Current Headlines
No Password Required
Events Calendar
No Password Required
HCBD-PRO Services
Search Companies
Search People
Search News|Events
Query News -
By Companies
By People
HR Announcements
Health Plan Industry
MailingList Rental
HCBD-EmailSend
Broadcast Email
HCBD Journalist Wire
News Distribution
Website | e-newsletter
Online Advertising
Trade Conf | Webinar
Event Promotion
Welcome <Guest>
Login
Daniel Leonard
Former President
National Pharmaceutical Council (NPC)
Office Location:
Washington, DC USA
Company Information:
1717 Pennsylvania Ave NW
Suite 800
Washington,
DC
20006
USA
202-827-2100
HCBD Company Profile:
National Pharmaceutical Council (NPC)
Company Website:
http://www.npcnow.org
Contact the Company
In The News
Johnson & Johnson's Blasine Penkowski Elected National Pharmaceutical Council Board Chair
NPC's Dan Leonard: Best ideas aren’t always (or often) from Washington [Chain Drug Review]
NPC: Could expanding pre-deductible coverage help those with chronic conditions?
NPC: Public Input Is a Key Way to Improve Value Assessment Process
View all remaining In The Stories headlines
NPC in Specialty Pharmacy Times: Going Below the Headlines on Health Spending in Four Steps
NPC: Study of U.S. Commercial Health Plans Shows Widespread Variation in Coverage and Reimbursement for Specialty Medicines
NPC's Webinar: Barriers to Paying for Value
NPC: The Impact of PBM Rebates at the Pharmacy Counter
National Pharmaceutical Council Welcomes Four Biopharmaceutical Companies as Members
National Pharmaceutical Council Launches Going Below the Surface, a Research Initiative to Explore the Different Dimensions of Health Care Spending
Mark Nagy Elected National Pharmaceutical Council’s Chairman of the Board
National Pharmaceutical Council: Study Finds Disconnect Between Employers and PBMs Over Transparency, Rebates, Value and Contracts
NPC Request for Proposals: Beginning a Public Dialogue on Health Care Spending
Ipsen Biopharmaceuticals Joins National Pharmaceutical Council
National Pharmaceutical Council Comments on Revised ICER Value Assessment Framework
National Pharmaceutical Council Welcomes EMD Serono to Its Membership
National Pharmaceutical Council to Host Conference On Measuring Health Care Value and Impact on Patient Care
National Pharmaceutical Council Welcomes Mallinckrodt as Its Newest Member
NPC Stakeholder Survey: Impact of Comparative Effectiveness Research On Health Care Decision-Making Still Three to Five Years in the Future
NPC Webinar: 2016 Comparative Effectiveness Research and the Environment for Health Care Decision-Making
NPC: CMS Allows Broader Access to Taxpayer-Funded Databases, Helping Researchers Address Health Care Challenges
NPC Highlights Stakeholder Views on Comparative Effectiveness Research and the Environment for Health Care Decision-Making
NPC Webinar: Is comparative effectiveness research (CER) having an impact on health care decision-making?
Biogen Idec and Gilead Sciences Join the National Pharmaceutical Council
Michael Ciarametaro Joins National Pharmaceutical Council as Director of Research
NPC Annual Stakeholder Survey: Comparative Effectiveness Research Is Important, But Impact on Health Care Decision-Making Is Still on the Horizon
NPC: CER Collaborative Improving Health Outcomes Through New Comparative Evidence Tools
NPC Comments on CMS’ Proposed Changes to Protected Classes
Eli Lilly and Company Joins the National Pharmaceutical Council
NPC: New Peer-Reviewed Study Shows Mixed Results in ACO Medication Readiness To Achieve Quality, Cost Goals
National Pharmaceutical Council Celebrates 60 Years of Leadership in Health Policy Research
National Pharmaceutical Council Survey Shows Health Care Stakeholders Continue to Show Optimism About the Future Role of Comparative Effectiveness Research
Daiichi Sankyo CEO John Gargiulo Elected as National Pharmaceutical Council's Chairman of the Board
NPC Survey of Health Care Stakeholders Indicates Cautious Optimism About Use of Comparative Effectiveness Research in Decision-Making
National Pharmaceutical Council Selects Five Research Projects for Funding
AstraZeneca's Rich Fante Elected as National Pharmaceutical Council's Chairman of the Board
National Pharmaceutical Council Welcomes Shire as Its Newest Member
NPC: Survey of Health Care Stakeholders Indicates Comparative Effectiveness Research Development Heading in Positive Direction
National Pharmaceutical Council Comments on Patient-Centered Outcomes Research Institute Board of Governors
NPC Welcomes GlaxoSmithKline as New Member
National Pharmaceutical Council Welcomes New Member, Otsuka America Pharmaceutical, Inc.
New National Pharmaceutical Council Report Provides Guidance on Evaluating Comparative Effectiveness Studies
NBCH eValue8 Report Reveals Health Plans’ Ability to Align Employee Incentives to Improve Health
NPC-PMC: Leaders in Healthcare to Examine Impact of Comparative Effectiveness Research on Personalized Medicine
National Pharmaceutical Council: Value-Based Insurance Design - Helping Employers Improve the Value of Health Care
Most Employers Underestimate Full Costs of Employee Health on Productivity
National Pharmaceutical Council on Economic Stimulus Package: Comparative Effectiveness Research Funding Should Target Improvements in Quality of Patient Care
Dan Leonard to Lead National Pharmaceutical Council
Professional Affiliations
Senior Health Advisor
Edelman
Founder - Granite Capitol Consulting
-consulting practice-
Former Chief Executive Officer
Association for Accessible Medicines (AAM)
Former President
National Pharmaceutical Council (NPC)
Former Exeecutive Vice President
AHIP
Biographic Information
Biographical information is available with Client Login.
About Us
|
Purchase Pro
|
Contact Us
© 2006-2010 Healthcare BizDev, Inc. All rights reserved.
Privacy Policy
|
Legal Conditions